Kala Bio (KALA) Net Income (2016 - 2026)
Kala Bio's (KALA) quarterly Net Income came in at -$1.6 million in Q2 2026, up 86.49% year-over-year from -$847769.0 in Q2 2025, and up 8.51% quarter-over-quarter from -$1.7 million in Q1 2026.
Analysis
Kala Bio (KALA) Net Income (2016 - 2026) Analysis & Trends
Kala Bio has disclosed Net Income across 11 years of filings, most recently posting -$1.6 million for Q2 2026.
- In Q2 2026, Net Income rose 86.49% year-over-year to -$1.6 million; the TTM figure through Jun 2026 stood at -$21.6 million (up 51.19% YoY), while the FY2025 annual figure was -$41.3 million, up 7.63% from the prior year.
- Net Income came in at -$1.6 million for Q2 2026 at Kala Bio, up from -$1.7 million in the prior quarter.
- In the past five years, Net Income ranged from a high of -$1.6 million in Q2 2026 to a low of -$32.9 million in Q1 2022.
- Average Net Income over 5 years is -$12.2 million, with a median of -$10.7 million recorded in 2024.
- Year-over-year, Net Income dropped 14.54% in 2024 and soared 86.49% in 2026.
- Over 5 years, Net Income stood at -$11.5 million in 2022, then increased by 8.69% to -$10.5 million in 2023, then gained by 0.99% to -$10.4 million in 2024, then climbed by 0.07% to -$10.4 million in 2025, then surged by 84.75% to -$1.6 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$1.6 million in Q2 2026, -$1.7 million in Q1 2026, and -$10.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Kala Bio | 7.80 Mn | 7.80 Mn | - | -1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.58 Mn |
| Mar 31, 2026 | -1.73 Mn |
| Dec 31, 2025 | -10.37 Mn |
| Sep 30, 2025 | -7.93 Mn |
| Jun 30, 2025 | -11.70 Mn |
| Mar 31, 2025 | -11.30 Mn |
| Dec 31, 2024 | -10.37 Mn |
| Sep 30, 2024 | -10.90 Mn |
| Jun 30, 2024 | -10.56 Mn |
| Mar 31, 2024 | -12.88 Mn |
| Dec 31, 2023 | -10.48 Mn |
| Sep 30, 2023 | -9.51 Mn |
| Jun 30, 2023 | -10.29 Mn |
| Mar 31, 2023 | -12.48 Mn |
| Dec 31, 2022 | -11.47 Mn |
| Sep 30, 2022 | -15.78 Mn |
| Jun 30, 2022 | -28.11 Mn |
| Mar 31, 2022 | -32.94 Mn |
| Dec 31, 2021 | -48.88 Mn |
| Sep 30, 2021 | -28.13 Mn |